在固体瘤治疗中,双特异性抗体与化疗相结合,前进的道路?
Yici Yan1, Jing Yuan1, Yanyang Peng2
1The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.
Frontiers in immunology
|May 12, 2025
概括
与化疗相结合的双特异性抗体显著改善了与单独化疗相比,患者的生存率和反应率. 这种组合疗法对女性,亚洲人和年轻患者具有特别的益处,副作用通常是可以控制的.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 药理学 药理学是指药理学的学科.
背景情况:
- 双特异性抗体 (bsAbs) 在抗癌治疗中提供了一种新的方法.
- 化学疗法本身在实现预期寿命目标方面存在局限性.
- 结合bsAbs与化疗的安全性和有效性需要进一步研究.
研究的目的:
- 在癌症治疗中,系统地评估双特异抗体 (bsAbs) 与化疗相结合的疗效和安全性,而不是单独使用化疗.
- 确定可能从bsAb+化疗组合治疗中受益最多的患者子组.
主要方法:
- 在PubMed,Embase和Cochrane数据库中进行了系统的文献搜索,截至2025年1月.
- 关键的疗效终点包括无进展生存率 (PFS),总生存率 (OS) 和总响应率 (ORR).
- 通过分析不良影响 (AE) 来评估安全性;出版偏差和异质性也得到了检查.
主要成果:
- 分析了8项符合条件的研究,涉及2,495名患者.
- 与单独化疗相比,BsAb+化疗显著改善了PFS,OS和ORR (所有患者的p<0.01).
- 亚组分析表明,女性,亚洲人,年轻 (65岁以下) 患者和接受IgG类bsAbs的患者的结果优越;可控的副作用被注意到.
结论:
- 结合治疗与bsAbs和化疗优于化疗单一治疗,改善了生存率和反应率.
- 特定的患者群体 (女性,亚洲人,年轻人) 和bsAb类型 (IgG类型) 与增强的益处有关.
- 虽然通常是可控的,但与bsAb+化疗相关的不良事件需要持续监测和潜在优化.
相关概念视频
Tumor Immunotherapy
406
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
406
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Cancer Vaccines
260
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
260
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K


